Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found that those treated with anticoagulants such as heparin and warfarin lived longer than those who didn't receive the medications. Use of blood thinners was associated with a 39% increase in overall survival. The study looked at patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

Full Story:
HealthDay News

Related Summaries